Carbohydrate but not fat is associated with elevated aminotransferases

Alimentary Pharmacology and Therapeutics

Volumn 35, Issue 9, 2012, Pages 1064-1072

  Kwon, O W ^a   Jun, D W ^a   Lee, S M ^b   Lee, K N ^a   Lee, H L ^a   Lee, O Y ^a   Yoon, B C ^a   Choi, H S ^a  

^a Hanyang University College of Medicine   (South Korea)

^b Sungshin Women's University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; CARBOHYDRATE; FAT;

ADULT; AGE DISTRIBUTION; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CALORIC INTAKE; CARBOHYDRATE ANALYSIS; CARBOHYDRATE INTAKE; DISEASE ASSOCIATION; ENZYME ACTIVITY; FAT INTAKE; FEMALE; FOOD COMPOSITION; HUMAN; HYPERTRANSAMINASEMIA; KOREA; LIVER DYSFUNCTION; MACRONUTRIENT; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; DIETARY CARBOHYDRATES; DIETARY FATS; ENERGY INTAKE; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NUTRITION SURVEYS; OBESITY; REPUBLIC OF KOREA; TRANSAMINASES; YOUNG ADULT;

EID: 84875693226     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2012.05061.x     Document Type: Article

References (34)

1. Kim HC, Nam CM, Jee SH, Han KH, Oh DK, Suh I. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ 2004; 328: 983.
2. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003; 98: 960-7.
3. Loria P, Lonardo A, Carulli L, et al. Review article: the metabolic syndrome and non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2005; 22 (Suppl. 2): 31-6.
4. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-31.
5. Bellentani S, Dalle Grave R, Suppini A, Marchesini G. Behavior therapy for nonalcoholic fatty liver disease: the need for a multidisciplinary approach. Hepatology 2008; 47: 746-54.
6. Younossi ZM. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2008; 28: 2-12.
7. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-421.
8. Hession M, Rolland C, Kulkarni U,Wise A, Broom J. Systematic review of randomized controlled trials of lowcarbohydrate vs. low-fat/low-calorie diets in the management of obesity and its comorbidities. Obes Rev 2009; 10: 36-50.
9. Brinkworth GD, Noakes M, Keogh JB, Luscombe ND, Wittert GA, Clifton PM. Long-term effects of a high-protein, lowcarbohydrate diet on weight control and cardiovascular risk markers in obese hyperinsulinemic subjects. Int J Obes Relat Metab Disord 2004; 28: 661-70.
10. Cardillo S, Seshadri P, Iqbal N. The effects of a low-carbohydrate versus low-fat diet on adipocytokines in severely obese adults: three-year followup of a randomized trial. Eur Rev Med Pharmacol Sci 2006; 10: 99-106.
11. Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA 2005; 293: 43-53.
12. Foster GD, Wyatt HR, Hill JO, et al. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med 2003; 348: 2082-90.
13. Song YJ, Lee YJ, Choi BJ, et al. Tailored therapy for treatment-naive chronic hepatitis C with pegylated interferon-a and ribavirin: real practice experience. Korean J Hepatol 2010; 16: S57.
14. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
15. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev 2005; 13: 322-7.
16. Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002; 137: 1-10.
17. Jacobson IM, Gonzalez SA, Ahmed F, et al. A randomized trial of pegylated interferon alpha-2b plus ribavirin in the retreatment of chronic hepatitis C. Am J Gastroenterol 2005; 100: 2453-62.
18. Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of nonalcoholic fatty liver disease. Dig Dis 2010; 28: 155-61.
19. Park SH, Jeon WK, Kim SH, et al. Prevalence and risk factors of nonalcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol 2006; 21: 138-43.
20. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-63.
21. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40: 1387-95.
22. Bambha K, Belt P, Abraham M, et al. Ethnicity and nonalcoholic fatty liver disease. Hepatology 2012; 55: 769-80.
23. Hollingsworth KG, Abubacker MZ, Joubert I, Allison ME, Lomas DJ. Lowcarbohydrate diet induced reduction of hepatic lipid content observed with a rapid non-invasive MRI technique. Br J Radiol 2006; 79: 712-5.
24. Muzio F, Mondazzi L, Harris WS, Sommariva D, Branchi A. Effects of moderate variations in the macronutrient content of the diet on cardiovascular disease risk factors in obese patients with the metabolic syndrome. Am J Clin Nutr 2007; 86: 946-51.
25. Nordmann AJ, Nordmann A, Briel M, et al. Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a metaanalysis of randomized controlled trials. Arch Intern Med 2006; 166: 285-93.
26. Nseir W, Nassar F, Assy N. Soft drinks consumption and nonalcoholic fatty liver disease. World J Gastroenterol 2010; 16: 2579-88.
27. Ouyang X, Cirillo P, Sautin Y, et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 2008; 48: 993-9.
28. Boden G. High- or low-carbohydrate diets: which is better for weight loss, insulin resistance, and fatty livers? Gastroenterology 2009; 136: 1490-2.
29. Zivkovic AM, German JB, Sanyal AJ. Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am J Clin Nutr 2007; 86: 285-300.
30. Skilton MR, Laville M, Cust AE, Moulin P, Bonnet F. The association between dietary macronutrient intake and the prevalence of the metabolic syndrome. Br J Nutr 2008; 100: 400-7.
31. Capanni M, Calella F, Biagini MR, et al. Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with nonalcoholic fatty liver disease: a pilot study. Aliment Pharmacol Ther 2006; 23: 1143-51.
32. Shin HR. Epidemiology of hepatitis C virus in Korea. Intervirology 2006; 49: 18-22.
33. Faeh D, Minehira K, Schwarz JM, Periasamy R, Park S, Tappy L. Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes 2005; 54: 1907-13.
34. Funaki M. Saturated fatty acids and insulin resistance. J Med Invest 2009; 56: 88-92.